Search

Author/Creator Wu, K

1. 1165PPreliminary safety, pharmacokinetics (PK) and efficacy results from a phase I study of CS1001, an anti-programmed death ligand-1 (PD-L1) monoclonal antibody (mAb) in patients (pts) with advanced tumors. (23rd October 2018)

Authors:
Shen, L; Cao, J; Gong, J; Ji, D; Qin, Z; Dai, H; Wu, K; Xu, J; Yang, J
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 123 In vivo evidence of COMT val158met functional polymorphism modulates different levels of dopamine turnover in Parkinson's disease: an 18F-dopa PET study. Issue 3 (9th February 2012)

Authors:
Wu, K; O'Keeffe, D; Politis, M; O'Keeffe, G; Bose, S; Brooks, D J; Barker, R; Piccini, P
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 83:Issue 3(2012)
Page Start:
e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Accretion geometry of the neutron star low mass X-ray binary Cyg X-2 from X-ray polarization measurements. Issue 3 (20th December 2022)

Authors:
Farinelli, R; Fabiani, S; Poutanen, J; Ursini, F; Ferrigno, C; Bianchi, S; Cocchi, M; Capitanio, F; De Rosa, A; Gnarini, A; Kislat, F; Matt, G; Mikusincova, R; Muleri, F; Agudo, I; Antonelli, L A; Bachetti, M; Baldini, L; Baumgartner, W H; Bellazzini, R
Journal:
Monthly notices of the Royal Astronomical Society
Issue:
Volume 519:Issue 3(2023)
Page Start:
3681
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗